Steven Adams hasn’t played with his Memphis Grizzlies since the end of January as a knee injury has kept him sidelined.
The team has been able to work hard and find success without him and is currently the third-best team in the Western Conference.
But Memphis has been eagerly awaiting Adams’ return.
Sadly, they’ll have to wait some more.
NBA writer Tim Bontemps is reporting that Adams received a stem cell injection in his injured knee and will be re-evaluated in four weeks.
This means that he will miss the rest of the regular season and could also miss the start of the playoffs too.
The Grizzlies announced Steven Adams got a stem cell injection in his injured knee and will be re-evaluated in four weeks — meaning he’ll miss the remainder of the regular season, at minimum.
— Tim Bontemps (@TimBontemps) March 9, 2023
The recovery process for an injection like this is typically about four weeks, which means the repairing process should be done right around the start of the postseason.
Adams could be a huge boost for the team in the playoffs as he has been averaging 8.6 points, 11.5 rebounds, and 1.1 blocks during his 42 games this season.
For the last few weeks, Adams has been listed as day-to-day, leading many fans to speculate that he could be back on the court at any time.
This latest announcement puts that speculation to rest but a tentative return date could be revealed soon.
The Grizzlies haven’t had it easy lately.
Brandon Clarke tore his Achilles and, of course, Ja Morant is out due to off-the-court problems.
Still, they are in a very strong position as the regular season concludes.
The Grizzlies will look to Xavier Tillman and continue to start him, hoping he can continue to fill the void left by Adams’ very big shoes for the foreseeable future.
NEXT: Another Grizzlies Veteran Will Reportedly Miss Time
